Rickets

Paediatrics and Child Health

Volumn 17, Issue 7, 2007, Pages 279-287

  Dimitri, Paul ^a   Bishop, Nick ^a  

^a NONE

Author keywords

1,25 dihydroxyvitamin D; 25 hydroxyvitamin D; hypophosphataemic rickets; osteomalacia; rickets; vitamin D; vitamin D dependent rickets

Indexed keywords

ARTICLE; CALCIUM DEFICIENCY; CALCIUM HOMEOSTASIS; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; ENTEROPATHY; ETHNIC GROUP; HUMAN; IMMIGRATION; KIDNEY DISEASE; LIVER DISEASE; METABOLIC BONE DISEASE; NONHUMAN; PANCREAS DISEASE; PATHOGENESIS; PHOSPHATE DEFICIENCY; RARE DISEASE; RICKETS; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; WESTERN EUROPE;

EID: 34347352146     PISSN: 17517222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.paed.2007.04.004     Document Type: Article

References (120)

1. Tanner J.M., and Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity and weight velocity and the stages of puberty. Arch Dis Child 51 (1976) 170-179
2. Fomon S.J., Haschke F., Ziegler E.E., et al. Body composition of reference children from birth to age 10 years. Am J Clin Nutr 35 (1982) 1169-1175
3. Dickerson J.W.T. Changes in the composition of the human femur during growth. Biochem J 82 (1962) 56-61
4. Yilmaz D., Ersoy B., Bilgin E., et al. Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parameters. J Bone Miner Metab 23 (2005) 476-482
5. Whiting S.J., Vatanparast H., Baxter-Jones A., et al. Factors that affect bone mineral accrual in the adolescent growth spurt. J Nutr 134 (2004) 696S-700S
6. Gilbert S. Developmental biology. 6th Edn (2000), Sinauer Associates, Sunderland
7. Pettifor J.M., Pentopoulos M., Moodley G.P., et al. Is craniotabes a pathognomonic sign of rickets in 3-month-old infants?. S Afr Med J 7 (1984) 549-551
8. De Jong A., Callahan C., and Weiss J. Pseudotumor cerebri and nutritional rickets. Eur J Pediatr 143 (1985) 219-220
9. Hanafy M.M., Hassanein E.S., and el Khateeb S. Benign intracranial hypertension in vitamin D deficiency rickets associated with malnutrition. J Trop Pediatr Afr Child Health 13 (1967) 19-22
10. Willis F.R., and Beattie T. Craniosynostosis in X-linked hypophosphataemic rickets. J Paediatr Child Health 33 (1997) 78-79
11. Bereket A., Casur Y., Firat P., et al. Brown tumour as a complication of secondary hyperparathyroidism in severe long-lasting vitamin D deficiency rickets. Eur J Pediatr 159 (2000) 931
12. Rugg-Gunn A.J., Al-Mohammadi S.M., and Butler T.J. Malnutrition and developmental defects of enamel in 2- to 6-year-old Saudi boys. Caries Res 32 (1998) 181-192
13. Nikiforuk G., and Fraser D. The etiology of enamel hypoplasia: a unifying concept. J Pediatr 98 (1981) 888-893
14. Purvis R.J., Barrie W.J.M., Mackay G.S., et al. Enamel hypoplasia of the teeth associated with neonatal tetany: manifestation of maternal vitamin deficiency. Lancet 2 (1973) 811-814
15. Uysal S., Kalayci A.G., and Baysal K. Cardiac functions in children with vitamin D deficiency rickets. Pediatr Cardiol 20 (1999) 283-286
16. Abdullah M., Bigras J.L., and McCrindle B.W. Dilated cardiomyopathy as a first sign of nutritional vitamin D deficiency rickets in infancy. Can J Cardiol 15 (1999) 1304
17. Alyaarubi S., and Rodd C. Treatment of malabsorption vitamin D deficiency myopathy with intramuscular vitamin D. J Pediatr Endocrinol Metab 18 (2005) 719-722
18. Schott G.D., and Wills M.R. Muscle weakness in osteomalacia. Lancet i (1976) 626-629
19. Balkan C., Ersoy B., and Nese N. Myelofibrosis associated with severe vitamin D deficiency rickets. J Int Med Res 33 (2005) 356-359
20. Stephan J.L., Galambrun C., Dutour A., et al. Myelofibrosis: an unusual presentation of vitamin D-deficient rickets. Eur J Pediatr 159 (2000) 544
21. Hall B.K., and Miyake T. Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int J Dev Biol 39 (1995) 881-893
22. Atchley W.R., and Hall B.K. A model for development and evolution of complex morphological structures. Biol Rev Camb Philos Soc 66 (1991) 101-157
23. Caplan A.I., and Pechak D.G. The cellular and molecular embryology of bone formation. Bone Miner Res 5 (1987) 117-183
24. Harada S., and Roden G.A. Control of osteoblast function and regulation of bone mass. Nature 423 (2003) 349
25. Sabbagh Y., Carpenter T.O., and Demay M.B. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA 102 (2005) 9637-9642
26. Clemens T.L., Adams J.S., Henderson S.L., et al. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet i (1982) 74-76
27. Matsuoka L.Y., Wortsman J., Chen T.C., et al. Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med 126 (1995) 452-457
28. Brazerol W.F., McPhee A.J., Mimouni F., et al. Serial ultraviolet B exposure and serum 25 hydroxyvitamin D response in young adult American blacks and whites: no racial differences. J Am Coll Nutr 7 (1988) 111-118
29. Specker B.L., Valanis B., Hertzberg V., et al. Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infants. J Pediatr 107 (1985) 372-376
30. Ladizesky M., Holick M.F., Mautalen C., et al. Solar ultraviolet B radiation and photoproduction of vitamin D3 in central and southern areas of Argentina. J Bone Miner Res 10 (1995) 545-549
31. Pettifor J.M., Lu Z., Holick M.F., et al. The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa. S Afr Med J 86 (1996) 1270-1272
32. Webb A.R., Kline L., and Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67 (1988) 373-378
33. Matsuoka L.Y., Ide L., Wortsman J., et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64 (1987) 1165-1168
34. Matsuoka L.Y., Wortsman J., Hanifan N., et al. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: a preliminary study. Arch Dermatol 124 (1988) 1802-1804
35. Grover S.R., and Morley R. Vitamin D deficiency in veiled or dark-skinned pregnant women. Med J Aust 175 (2001) 251-252
36. Robinson P.D., Cowell C.T., Ambler G.R., et al. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis Child 91 (2006) 564-568
37. Dawson-Hughes B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am J Clin Nutr 80 (2004) 1763S-1766S
38. Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom. Report on health and social subjects vol. 41 (1991), HMSO, London
39. Mills A.M., and Tyler H. Food and nutrient intakes of British infants aged 6-12 months (1992), HMSO, London
40. Gregory J.R., Collins D.L., Davies P.S.W., et al. National diet and nutrition survey: children aged 1 1/2 to 4 years (1995), HMSO, London
41. Gregory J., and Lowe S. National diet and nutrition survey: young children aged 4 to 18 years (2000), Stationery Office, London 796
42. Zhu Y., Goff J.P., Reinhardt T.A., et al. Pregnancy and lactation increase vitamin D-dependent intestinal membrane calcium adenosine triphosphatase and calcium binding protein messenger ribonucleic acid expression. Endocrinology 139 (1998) 3520-3524
43. Nozza J.M., and Rodda C.P. Vitamin D deficiency in mothers of infants with rickets. Med J Aust 175 (2001) 253-255
44. Park W., Paust H., Kaufmann H.J., et al. Osteomalacia of the mother: rickets of the newborn. Eur J Pediatr 146 (1987) 292-293
45. Carvalho N.F., Kenney R.D., Carrington P.H., et al. Severe nutritional deficiencies in toddlers resulting from health food milk alternatives. Pediatrics 107 (2001) E46
46. Lawson M., and Thomas M. Vitamin D concentrations in Asian children aged 2 years living in England: population survey. BMJ 318 (1999) 28
47. Shaw N.J., and Pal B.J. Vitamin D deficiency in UK Asian families: activating a new concern. Arch Dis Child 86 (2002) 147-149
48. Awumey E.M., Mitra D.A., Hollis B.W., et al. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 83 (1998) 169-173
49. Grindulis H., Scott P.H., Belton N.R., et al. Combined deficiency of iron and vitamin D in Asian toddlers. Arch Dis Child 61 (1986) 843-848
50. Wharton B., and Bishop N. Rickets. Lancet 362 (2003) 1389-1400
51. Bawa S. The role of the consumption of beverages in the obesity epidemic. J R Soc Health 125 (2005) 124-128
52. Kristensen M., Jensen M., Kudsk J., et al. Short-term effects on bone turnover of replacing milk with cola beverages: a 10-day interventional study in young men. Osteoporos Int 16 (2005) 1803-1808
53. Benda C.E., Bronner F., Harris R.S., et al. Studies in calcium metabolism, effect of food phytates on calcium 45 uptake in boys on a moderate calcium breakfast. J Nutr 59 (1956) 393-406
54. Zhang Z.B., Kornegay E.T., Radcliffe J.S., et al. Comparison of phytase from genetically engineered Aspergillus and canola in weanling pig diets. J Anim Sci 78 (2000) 2868-2878
55. MacLaughlin J.A., Anderson R.R., and Holick M.F. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science 216 (1982) 1001-1003
56. Blunt J.W., Tanaka Y., and DeLuca H.F. Biological activity of 25-hydroxycholecalciferol, a metabolite of vitamin D3. Proc Natl Acad Sci USA 61 (1968) 1503-1506
57. Holick M.F. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 77 (1981) 51-58
58. Tian X.Q., Chen T.C., Matsuoka L.Y., et al. Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem 268 (1993) 14888-14892
59. Prosser D.E., and Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29 (2004) 664-673
60. Cheng J.B., Levine M.A., Bell N.H., et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci 101 (2004) 7711-7715
61. 2 vitamin D3 synthesis in the kidney. Nature 276 (1978) 287-289
62. Zehnder D., Hewison M., Stewart P.M., et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10 (1999) 2465-2473
63. Brenza H.L., Sud T., DeLuca H.F., et al. Parathyroid hormone activation of the 25-hydroxyvitamin D3-1-alpha-hydroxylase gene promoter. Proc Natl Acad Sci 95 (1998) 1387-1391
64. Kawashima H., Torikai S., and Kurokawa K. Calcitonin selectively stimulates 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase in the proximal straight tubule of the rat kidney. Nature 291 (1981) 327-329
65. Makin G., Lohnes D., Byford V., et al. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262 (1989) 173-180
66. Reddy G.S., and Tserng K.Y. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 28 (1989) 1763-1769
67. Sakaki T., Sawada N., Komai K., et al. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur J Biochem 267 (2000) 6158-6165
68. Knutson J.C., and DeLuca H.F. 25-hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties?. Biochemistry 13 (1974) 1543-1548
69. Anderson P.H., O'Loughlin P.D., May B.K., et al. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone 36 (2005) 654-662
70. Armbrecht H.J., Hodam T.L., Boltz M.A., et al. Induction of the vitamin D 24-hydroxylase (CYP24) by 1,25-dihydroxyvitamin D3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology 139 (1998) 3375-3381
71. Kimmel-Jehan C., Jehan F., and DeLuca H.F. Salt concentration determines 1,25-dihydroxyvitamin D 3 dependency of vitamin D receptor-retinoid X receptor-vitamin D-responsive element complex formation. Arch Biochem Biophys 34 (1997) 75-80
72. Jehan-Kimmel C., Darwish H.M., Strugnell S.A., et al. Binding of vitamin D receptor to vitamin D response elements induces DNA distortion (abstract). J Bone Miner Res 11 (1996) S312
73. Gamble M.J., and Freedman L.P. A coactivator code for transcription. Trends Biochem Sci 27 (2002) 165-167
74. Masuyama H., Brownfield C.M., St-Arnaud R., et al. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol Endocrinol 11 (1997) 1507-1517
75. Brenza H.L., and DeLuca H.F. Regulation of 25-hydroxyvitamin D3 1-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 381 (2000) 143-152
76. Van Cromphaut S., Dewerchin M., Carmeliet G., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci 98 (2001) 13324-13329
77. Holick M.F. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 9 (2002) 87-98
78. Jimi E., Nakamura I., Amano H., et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137 (1996) 2187-2190
79. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci 95 (1998) 3597-3602
80. Fu G.K., Portale A.A., and Miller W.L. Complete structure of the human gene for the vitamin D 1-alpha-hydroxylase, P450cl-alpha. DNA Cell Biol 16 (1997) 1499-1507
81. St-Arnaud R., Messerlian S., Moir J.M., et al. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12 (1997) 1552-1559
82. Scriver C.R. Vitamin D dependency (editorial). Pediatrics 45 (1970) 361-363
83. Kitanaka S., Takeyama K., Sato T., et al. Inactivating mutations in the 25-hydroxyvitamin D3-1-alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338 (1998) 653-661
84. Wang X., Zhang M.Y., Miller W.L., et al. Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro. J Clin Endocrinol Metab 87 (2002) 2424-2430
85. Szpirer J., Szpirer C., DeLuca H.F., et al. The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D(3) receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics 11 (1991) 168-173
86. Feldman D.T., Chen C., Hochberg Z., et al. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab 55 (1982) 1020-1022
87. Hughes M.R., Malloy P.J., O'Malley B.W., et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242 (1988) 1702-1705
88. Malloy P.J., Hochberg Z., Pike J.W., et al. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J. Clin Endocrinol Metab 68 (1989) 263-269
89. Rosen J.F., Fleischman A.R., Finberg L., et al. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr 94 (1979) 729-735
90. Eil C., Liberman U.A., Rosen J.F., et al. A cellular defect in hereditary vitamin-D-dependent rickets type II: defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts. N Engl J Med 304 (1981) 1588-1591
91. Liberman U.A., Halabe A., O'Riordan J.L.H., et al. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet i (1980) 504-507
92. Fraher L.J., Karmali R., O'Riordan J.L.H., et al. Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D(3) in a patient without alopecia. Eur J Pediatr 145 (1986) 389-395
93. Kudoh T., Kumagai T., and Nakao T. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur J Pediatr 137 (1981) 307-311
94. Marx S.J., Bliziotes M.M., and Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol 25 (1986) 373-381
95. Balsan S., Garabedian M., Ricour C., et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77 (1986) 1661-1667
96. al-Aqeel A., Ozand P., Sobki S., et al. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII). Clin Endocrinol 39 (1993) 229-237
97. Takeda E., Yamamoto H., Nashiki K., et al. Inorganic phosphate homeostasis and the role of dietary phosphorus. J Cell Mol Med 8 (2004) 191-200
98. Shimada T., Hasegawa H., Muto T., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. JBMR 19 (2004) 429-435
99. HYP Consortium. A gene (HYP) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11 (1995) 130-136
100. Lipman M.L., Panda D., Karaplis A.C., et al. Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity. J Biol Chem 273 (1998) 13729-13737
101. Beck L, Soumounou Y, Tenenhouse HS, et al., Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-Iinked hypo-phosphatemic mice. J Clin Invest 1197;99: 1200-1209.
102. Ruchon A.F., Marcinkiewicz M., Boileau G., et al. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 46 (1998) 459-468
103. Du L., Desbarats M., Viel J., et al. cDNA cloning of the murine Pex gene and evidence for expression in bone. Genomics 36 (1996) 22-28
104. Blydt-Hansen T.D.M., Tenenhouse H.S., and Goodyer P. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr Nephrol 13 (1999) 607-611
105. Jain A., Fedarko N.S., Fisher L.W., et al. Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density. J Clin Endocrinol Metab 89 (2004) 4158-4161
106. Liu S., Brown T.A., Quarles L.D., et al. Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia. J Am Soc Nephrol 16 (2005) 1645-1653
107. Shimada T., Hasegawa H., and Yamashita T. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19 (2004) 429-435
108. Quarles L.D. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285 (2003) E1-E9
109. Econs M.J., McEnery P.T., Lennon F., et al. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. J Clin Invest 100 (1997) 2653-2657
110. Sabbagh Y., Londowski J.M., Kumar R., et al. Stable transfection of PHEX in hypophosphatemic (Hyp) osteoblasts using a viral vector partially corrects the mutant cell phenotype. Implications for gene therapy. J Am Soc Nephrol 11 (2000) 413A
111. Econs M.J., and McEnery M.T. Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82 (1997) 674-681
112. Ziegler E.E., O'Donnell A.M., Nelson S.E., et al. Body composition of the reference fetus. Growth 40 (1976) 329-341
113. Bishop N. Bone disease in preterm infants. Arch Dis Child 64 (1989) 1403-1409
114. Fewtrell M.S., Cole T.J., Bishop N.J., et al. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease?. J Pediatr 137 (2000) 668-673
115. Lucas A., Brooke O.G., Baker B.A., et al. High plasmaalkaline phosphatase activity and growth in preterm neonates. Arch Dis Child 64 (1989) 902-909
116. Faerk J., Peitersen B., Petersen S., et al. Bone mineralisation in premature infants cannot be predicted from serum alkaline phosphatase or serum phosphate. Arch Dis Child 87 (2002) 133-136
117. Abrams S.A., Schanler R.J., and Garza C. Bone mineralization in former very low birth weight infants fed either human milk or commercial formula. J Pediatr 112 (1988) 956-960
118. Bishop N.J., King F.J., and Lucas A. Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital. Arch Dis Child 68 (1993) 573-578
119. Beyers N., Alheit B., Taljaard J.F., et al. High turnover osteopenia in preterm babies. Bone 15 (1994) 5-13
120. Moyer-Mileur L.J., Brunstetter V., McNaught T.P., et al. Daily physical activity program increases bone mineralization and growth in preterm very low birth weight infants. Pediatrics 106 (2000) 1088-1092